tenk.fyi

Lantheus Holdings, Inc.

LNTHNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$1.5B

0.5% YoY

Net Income

$233.6M

25.2% YoY

EPS

$3.41

21.8% YoY

Cash

$359.1M

60.7% YoY

FY 2025 · As of 2025-12-31